RayzeBio, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: RayzeBio, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2022 to Q3 2023.
RayzeBio, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2023 was -$180M.

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	-$180M			Sep 30, 2023	10-Q	2023-11-13
Q4 2022	-$130M			Dec 31, 2022	10-Q	2023-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.